Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04765709 |
| Title | Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC (BRIDGE) |
| Acronym | BRIDGE |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Mario Negri Institute for Pharmacological Research |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Gustave Roussy Institute | Paris | France | Details | |||
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan | 20133 | Italy | Details | ||
| Vall d'Hebron Barcelona Hospital | Barcelona | Spain | Details |